Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02102386 · ClinicalTrials.gov registry record
Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 13
- Enrollment target
NCT02102386: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT02102386 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02102386 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The goal of this study is to demonstrate Or-Nim's CerOx monitor ability to monitor changes in cerebral blood flow and oximetry during CEA surgery. Procedures include: Screening: ECG, blood draw, neurological assessment, NIHSS study: CerOX and TCD clock during CEA procedure, data collection from the medical record/monitors, neurological assessment, NIHSS 30 day follow-up
Primary Outcome
compare cerebral perfusion and Oximetry changes to arterial blood pressure and trans-cranial doppler velocity changes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-01 |
Why NCT02102386 stopped before completion
NCT02102386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02102386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02102386 about?
NCT02102386 is a clinical study titled "Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries". The goal of this study is to demonstrate Or-Nim's CerOx monitor ability to monitor changes in cerebral blood flow and oximetry during CEA surgery. Procedures include: Screening: ECG, blood draw, neurological assessment, NIHSS study: CerOX and TCD clock during CEA procedure, data collection from ...
What is the current status of trial NCT02102386?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2014-02. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT02102386?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia